Reference List Osteoarthritis - American College of Rheumatology

More documents

Recommendations

Info

Congress on Osteoporosis and Osteoarthritis, ECCEO11-IOF, 2011 Mar 23 - 26; Valencia (Spain). 7. Wildi L, Raynauld J-P, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F ,et al. Chondroitin sulfate reduces both cartilage volume loss and bone marrow lesions in knee OA patients starting as early as 6 months after initiation of therapy: A randomized, double-blind placebo controlled pilot study using MRI. Osteoporos Int 2011, conference publication S137; European Congress on Osteoporosis and Osteoarthritis, ECCEO11-IOF, 2011 Mar 23 - 26; Valencia (Spain). 8. Berembaum F, Maheu E, Grifka J, Cazzaniga S, D'Amato M, Giacovelli G ,et al. Intermediate molecular weight hyaluronic acid (GO-ON) is superior to the low molecular weight standard preparation (Hyalgan) in symptom control of knee osteoarthritis over 6 months. Osteoporos Int 2011, conference publication:S110; European Congress on Osteoporosis and Osteoarthritis, ECCEO11-IOF, 2011 Mar 23 - 26; Valencia (Spain). 9. Reginster JY. The true clinical relevance of crystalline glucosamine sulphate in the treatment of knee osteoarthritis. Osteoporos Int 2011, conference publication S410; European Congress on Osteoporosis and Osteoarthritis, ECCEO11-IOF, 2011 Mar 23 - 26; Valencia (Spain). 10. McDonald D, Walsh S, Vergara C, Gifford T. The effect of a virtual pain coach on pain management discussions: A pilot study. J Pain 2011,conference publication 85; 30th Annual Scientific Meeting of the American Pain Society, 2011 May 19 - 21; Austin (TX). 11. Tsai P, Chang J, Beck C, Kuo Y. A randomized controlled trial of a 20 week Tai Chi program for osteoarthritic knee pain in elders with mild dementia. J Pain 2011,conference publication 71; 12. Roth S, Fuller P. Safety of diclofenac topical solution compared with oral diclofenac for treatment of osteoarthritis of the knee in patients aged >=65 years: Pooled analysis from 2 controlled clinical trials. J Pain 2011, conference publication 66; 30th Annual Scientific Meeting of the American Pain Society, 2011 May 19 - 21; Austin (TX). 13. Petruschke R, Altman R, Huskisson E, Fotopoulos G, Gold M, Wieman M. Cardiovascular and gastrointestinal safety of topical diclofenac gels. J Pain 2011, conference publication 66; 30th Annual Scientific Meeting of the American Pain Society, 2011 May 19 - 21; Austin (TX). 14. Petruschke R, Peniston J, Gold M, Wieman M, Altman R. Gastrointestinal and hepatic safety of diclofenac sodium 1% gel in patients with hand and knee osteoarthritis. J Pain 2011, conference Publication 66; 30th Annual Scientific Meeting of the American Pain Society, 2011 May 19 - 21; Austin (TX). 15. Petruschke R, Peniston J, Gold M, Wieman M, Altman R. Effect sizes of diclofenac sodium 1% gel in randomized controlled trials of knee osteoarthritis. J Pain 2011, conference publication 65; 30th Annual Scientific Meeting of the American Pain Society, 2011 May 19 - 21; Austin (TX). 16. Biondi D, Xiang J, Etropolski M, Moskovitz B. A post hoc pooled data analysis to evaluate the gastrointestinal tolerability profile of tapentadol extended release (ER) versus oxycodone
controlled release (CR) in patients >=75 years of age. J Pain 2011, conference publication 56; 30th Annual Scientific Meeting of the American Pain Society, 2011 May 19 - 21; Austin (TX). 17. Biondi D, Xiang J, Etropolski M, Moskovitz B. A post hoc pooled data analysis to evaluate blood pressure (BP) and heart rate (HR) measurements in patients with a current or prior history of hypertension who received tapentadol ER, oxycodone CR, or placebo in chronic pain studies. J Pain 2011, conference publication 55; 30th Annual Scientific Meeting of the American Pain Society, 2011 May 19 - 21; Austin (TX). 18. Meng M, Liu LC, Ge B, Tang H, Wu YQ, Xu Y. Efficacy of celecoxib and naproxen for treating osteoarthritis or rheumatoid arthritis: a meta-analysis. Chin Med 2011;11:560-4. 19. Stuber K, Sajko S, Kristmanson K. Efficacy of glucosamine, chondroitin, and methylsulfonylmethane for spinal degenerative joint disease and degenerative disc disease: a systematic review. J Can Chiropr Assoc 2011;55:47-55. 20. Canadian Agency for Drugs and Technologies in Health (CADTH). Celecoxib versus nonselective non-steroidal anti-Inflammatory drugs and proton pump inhibitors: clinical effectiveness, safety, and cost-effectiveness. CADTH Rapid Response Report: Summary with Critical Appraisal 2011; PMID: http://www.cadth.ca/media/pdf/htis/dec-2011/RC0310- 000%20Celecoxib-PPI.pdf 21. Qi DS, May LG, Zimmerman BA, Peng PY, Atillasoy EO, Shelburne SN. Comparison of acetaminophen 1000 mg and acetaminophen 650 mg in an acute pain model: results from a randomized, double-blind, placebo-controlled, efficacy and safety study [abstract]. Osteoarthritis Cartilage 2012;20:S175. 22. Radner H, Ramiro S, Buchbinder R, Landewé Robert BM, van der Heijde D, Aletaha D. Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondyloarthritis) and gastrointestinal or liver comorbidity. Cochrane Database Syst Rev 2012; 23. Vrdoljak D, Selimovic M, Marin A, Utrobicic A, Tugwell P, Puljak L. Celecoxib for osteoarthritis. Cochrane Database Syst Rev 2012; 24. Guarda-Nardini L, Cadorin C, Frizziero A, Ferronato G, Manfredini D. Comparison of 2 hyaluronic acid drugs for the treatment of temporomandibular joint osteoarthritis. J Oral Maxillofac Surg 2012;70:2522-30. PMID: 22939642 25. Lanas A, Goldstein JL, Chan FK, Wilcox CM, Peura DA, Li C ,et al. Risk factors associated with a decrease >/=2 g/dL in haemoglobin and/or >/=10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR). Aliment Pharmacol Ther 2012;36:485-92. PMID: 22804104
Page 1: Reference List Osteoarthritis: Phar
Page 5 and 6: preparations differing by their mol
Page 7 and 8: 59. Brereton N, Winn B, Akehurst R.
Page 9 and 10: 83. Dorleijn DM, Luijsterburg PA, R
Page 11 and 12: 104. Petersen SG, Beyer N, Hansen M
Page 13 and 14: double-blind, placebo-controlled pi
Page 15 and 16: 147. Levy R, Khokhlov A, Kopenkin S
Page 17 and 18: 169. MacDonald TM, Richard D, Lheri
Page 19: 191. Derry S, Moore RA, Rabbie R. T

Reference List Osteoarthritis - American College of Rheumatology

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?